These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31924521)

  • 1. Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms.
    Kiyasu Y; Hitomi S; Funayama Y; Saito K; Ishikawa H
    J Infect Chemother; 2020 May; 26(5):475-482. PubMed ID: 31924521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical characteristics of Acinetobacter bacteremia differ among genomospecies: A hospital-based retrospective comparative analysis of genotypically identified strains.
    Koizumi Y; Sakanashi D; Ohno T; Yamada A; Shiota A; Kato H; Hagihara M; Watanabe H; Asai N; Watarai M; Murotani K; Yamagishi Y; Suematsu H; Mikamo H
    J Microbiol Immunol Infect; 2019 Dec; 52(6):966-972. PubMed ID: 31813733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States.
    Wisplinghoff H; Paulus T; Lugenheim M; Stefanik D; Higgins PG; Edmond MB; Wenzel RP; Seifert H
    J Infect; 2012 Mar; 64(3):282-90. PubMed ID: 22209744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.
    Song JY; Cheong HJ; Choi WS; Heo JY; Noh JY; Kim WJ
    J Med Microbiol; 2011 May; 60(Pt 5):605-611. PubMed ID: 21233298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
    Lee HY; Chen CL; Wu SR; Huang CW; Chiu CH
    Crit Care Med; 2014 May; 42(5):1081-8. PubMed ID: 24394630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
    Lee HY; Huang CW; Chen CL; Wang YH; Chang CJ; Chiu CH
    J Microbiol Immunol Infect; 2015 Dec; 48(6):588-96. PubMed ID: 26055692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
    Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
    J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
    Park YK; Jung SI; Park KH; Kim DH; Choi JY; Kim SH; Ko KS
    J Med Microbiol; 2012 Jan; 61(Pt 1):71-79. PubMed ID: 21852525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
    Lee HY; Hsu SY; Hsu JF; Chen CL; Wang YH; Chiu CH
    J Microbiol Immunol Infect; 2018 Jun; 51(3):367-376. PubMed ID: 28830746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of invasive Acinetobacter species isolates recovered in a pediatric academic center.
    Jain AL; Harding CM; Assani K; Shrestha CL; Haga M; Leber A; Munson RS; Kopp BT
    BMC Infect Dis; 2016 Jul; 16():346. PubMed ID: 27449800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics.
    Schuertz KF; Tuon FF; Palmeiro JK; Conte D; Telles JPM; Trevisoli LE; Dalla-Costa LM
    Braz J Microbiol; 2018 Nov; 49 Suppl 1(Suppl 1):199-204. PubMed ID: 29720352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii.
    Chusri S; Chongsuvivatwong V; Rivera JI; Silpapojakul K; Singkhamanan K; McNeil E; Doi Y
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4172-9. PubMed ID: 24820079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood stream infections caused by Acinetobacter baumannii group in Japan - Epidemiological and clinical investigation.
    Fujikura Y; Yuki A; Hamamoto T; Kawana A; Ohkusu K; Matsumoto T
    J Infect Chemother; 2016 Jun; 22(6):366-71. PubMed ID: 26993173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance.
    Wareham DW; Bean DC; Khanna P; Hennessy EM; Krahe D; Ely A; Millar M
    Eur J Clin Microbiol Infect Dis; 2008 Jul; 27(7):607-12. PubMed ID: 18283503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors, Clinical Presentation, and Outcome of
    Ballouz T; Aridi J; Afif C; Irani J; Lakis C; Nasreddine R; Azar E
    Front Cell Infect Microbiol; 2017; 7():156. PubMed ID: 28523249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.
    Zhou H; Yao Y; Zhu B; Ren D; Yang Q; Fu Y; Yu Y; Zhou J
    Medicine (Baltimore); 2019 Mar; 98(13):e14937. PubMed ID: 30921191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
    Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
    BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research and analysis of 74 bloodstream infection cases of Acinetobacter baumannii and drug resistance.
    Wu HG; Liu WS; Zhu M; Li XX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1782-1786. PubMed ID: 29630127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.